TNXP:NASDAQ
Tonix Pharmaceuticals Holding Corp
$12.28
arrow_downward
-4.29%(-0.55) 1D
$12.27
arrow_downward
-0.08% (-0.0100)bedtimeAfter hours
Closed: Sep 10, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TNXP...
Open
$12.70
High
$12.70
Low
$12.22
Mkt. cap
210.61M
Avg. vol.
456.07K
Volume
0.00
52-wk high
$31.55
52-wk low
$9.40
EPS
-$12.92
Beta
1.74
Shares outstanding
17.15M
No. of employees
142
Open
$12.70
High
$12.70
Low
$12.22
Mkt. cap
210.61M
Avg. vol.
456.07K
Volume
0.00
52-wk high
$31.55
52-wk low
$9.40
EPS
-$12.92
Beta
1.74
Shares outstanding
17.15M
No. of employees
142
News stories
From web sources and news partners
TradingView
·
11 hours ago
TNXP: Strong sales growth, pipeline progress, and robust cash position drive optimism for the next year
Investing.com
·
11 hours ago
Tonix Pharmaceuticals at Cantor conference: launch gains and pipeline push
https://www.dars.gov.et/
·
1 month ago
TNXP Q1 2026 Earnings: EPS Misses Estimates as Biotech Continues Pre-Revenue Phase - Revenue Warning Signal
Profile
Tonix Pharmaceuticals is a pharmaceutical company based in Chatham, New Jersey that focuses on repurposed drugs for central nervous system conditions and as of 2020 was also pursuing a vaccine for COVID-19 and a biodefense project. Wikipedia
About Tonix Pharmaceuticals Holding Corp
CEOSeth Lederman
Employees142
Founded2007
HeadquartersBerkeley Heights, New Jersey, United States
SectorBiotechnology
Websitetonixpharma.com